Opioids use disorder (OUD) is a chronic condition that affects millions of Americans. If left untreated it can result in serious consequences including increased morbidity, relapse, opioid overdose, and death. Medication-assisted treatment is effective for OUD and has been shown to decrease all-cause mortality and opioid overdose-related deaths. This pharmacist-driven training will provide detailed education on the induction and maintenance of medication-assisted treatment for opioid use disorder.
- Describe the epidemiology of opioid overdose and opioid use disorder in the United States
- Examine the prescribing patterns of opioids for chronic non-cancer pain over the past two decades
- Differentiate the clinical presentation of opioid dependence, opioid withdrawal and opioid use disorder
- Classify the pharmacology and therapeutics for methadone, buprenorphine/naloxone, and naltrexone for the treatment of opioid use disorder
- Discuss treatment considerations for patients with HIV and Opioid Use Disorder
Jasmine Carpenter, Pharm.D, BCPS, BCPP, mental health clinical pharmacist at a hospital in D.C. where she provides direct pharmaceutical care to patients of the mental health service and SUD rehab program. Jasmine also serves on the faculty of Howard University’s non-traditional Pharm. D program.